Teritemso 14 mg Tablet
PDF Leaflet Revision Date: 13 June 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of relapsing forms of multiple sclerosis in adults.
Dosage (summary)
14 mg orally once daily.
Special Populations
- Elderly population
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding; effective contraception required during treatment.
Key Drug Interactions
- Rifampicin
- Warfarin
- CYP2C8 substrates
Contraindications
- Severe hepatic impairment
- Pregnancy
- Breastfeeding
- Severe immunodeficiency
- Hypersensitivity
Common side effects
- Influenza
- Headache
- Diarrhoea
- Increased ALT
- Alopecia
Counselling Points
- Monitor liver enzymes monthly for 6 months
- Report signs of infection
- Avoid live vaccines
Serious warnings
- Hepatotoxicity
- Risk of teratogenicity
- Serious infections
Important Disclaimer
The Teritemso 14 mg Tablet professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
